UPDATE : Wednesday, January 22, 2020
Pharma industry group to support AI-based new drugs
Korea’s largest group of pharmaceutical companies said it would develop an ...
by So Jae-hyeon  |  2018-03-06 14:47
Multinationals led drug sales in Korea in 2017
Multinational pharmaceutical companies led the local sales of medicine in K...
by So Jae-hyeon  |  2018-03-06 11:38
YD applies for US clinical trial for diabetic macular edema treatment
YD Life Science said Monday that it submitted a phase 2a clinical trial app...
by Lee Han-soo  |  2018-03-05 17:38
SK Chemicals to market Bial’s Parkinson's disease treatment
SK Chemicals said Monday that it has signed a licensing agreement with Bial...
by Lee Han-soo  |  2018-03-05 15:33
KRX suspends trading on Kyung Nam Pharm
The Korea Exchange (KRX) announced Friday that the Securities and Futures C...
by Lee Han-soo  |  2018-03-02 14:55
Baxter taps Hyun Don as general manager of Korean branch
Baxter International Thursday appointed Hyun Don as the new general manager...
by Marian Chu  |  2018-03-02 12:03
Dong-A ST shifts marketing strategy to social contribution
Dong-A ST said Tuesday that it aims to shift the paradigm in sales activiti...
by Lee Han-soo  |  2018-02-28 15:12
Enzychem, InnoPharmax strike $75.3-million deal for MRI contrast agent
Enzychem Lifesciences said Tuesday that it struck an 81.5 billion won ($75....
by Marian Chu  |  2018-02-28 15:11
Daewoong to distribute 2 of AstraZeneca’s diabetes drugs
Daewoong Pharmaceutical will begin distributing two of AstraZeneca’s diabet...
by Marian Chu  |  2018-02-28 11:40
‘Upcoming dementia generics might not succeed’
With the government’s push to enhance the state’s role to fight dementia, l...
by So Jae-hyeon  |  2018-02-27 16:30
Local drugmakers shift focus to convenient drugs
Local drugmakers are diversifying their strategies into developing novel dr...
by So Jae-hyeon  |  2018-02-27 14:26
Eli Lilly Korea earned ₩12 billion from Trulicity sales in 2017
Eli Lilly and Company Korea said Tuesday that its diabetes treatment Trulic...
by Marian Chu  |  2018-02-27 13:52
Bridge Bio to start P1 trial for ulcerative colitis candidate drug
Bridge Biotherapeutics said Tuesday that it plans to start phase 1 clinical...
by Lee Han-soo  |  2018-02-27 11:39
MSD Korea gets larger coverage for Keytruda to treat melanoma
MSD Korea said Tuesday that it got expanded coverage for Keytruda (pembroli...
by Marian Chu  |  2018-02-27 11:33
Han Wha Pharma to sell allergen blocker cream
Han Wha Pharma said recently it would start selling Rhino-Protect PRS, a na...
by So Jae-hyeon  |  2018-02-26 15:46
‘Infusion time for Gaucher patients will be cut to 10 minutes’
Although several therapies for Gaucher disease exist, most take an hour to ...
by Marian Chu  |  2018-02-26 14:55
SK Chemicals to spin off vaccine biz
SK Chemicals said it would spin off its vaccine business, establish it as a...
by So Jae-hyeon  |  2018-02-26 14:34
National Cancer Center, Eutilex aim to develop new CAR-T therapy
A joint research team is developing a new type of chimeric antigen receptor...
by Marian Chu  |  2018-02-26 11:28
Will Koreans without HIV take Truvada braving social, cultural pressure?
Gilead Sciences’ Truvada recently gained an indication to be taken as a PrE...
by Marian Chu  |  2018-02-23 18:41
How will Kolmar raise W1.3 trillion to buy CJ HealthCare?
Kolmar Korea is expected to transform into a pharmaceutical giant with annu...
by So Jae-hyeon  |  2018-02-23 16:21
Back to Top